Status:
COMPLETED
Nocturnal Transnasal Insufflation (nTNI)
Lead Sponsor:
Institut für Pneumologie Hagen Ambrock eV
Collaborating Sponsors:
TNI Medical AG
Conditions:
COPD
Hypercapnia
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
On the basis of different studies the long term oxygen treatment is deemed to be routine treatment in patients suffering from chronic obstructive pulmonary disease (COPD) at appearance of hypoxaemia. ...
Eligibility Criteria
Inclusion
- Hypercapnia in Routine Blood Gas Analysis with \> 50 mmHg PCO2
- Clinically stable respiratory situation
- Treatment on normal ward possible
Exclusion
- Before known obstructive sleep apnea syndrome (OSA)
- A found OSA during study means no exclusion
- Any other severe or acute physical illness which requires intensive medical care
- Acute hypercapnic decompensation with pH \< 7.30 in capillary Blood Gas Analysis
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01499550
Start Date
August 1 2011
End Date
July 1 2012
Last Update
September 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helios Klinik Hagen Ambrock
Hagen, North Rhine-Westphalia, Germany, 58091